Market and market research report opinion about revenue impact?
the Endoscopes Reprocessing Market It is expected to reach $3.2 billion by 2026 from $2.1 billion in 2021, at a compound annual growth rate of 9.0% from 2021 to 2026.
Factors responsible for growth and in-depth analysis?
The increasing preference for endoscopic procedures, the higher risk of endoscopic-associated infection, the increasing number of elderly people and the subsequent increase in endoscopic procedures, and the increased focus on improving re-treatment guidelines by health care facilities in the market during the forecast period.
- In 2021, Getinge partnered with researchers from the School of Business, Economics and Law at the University of Gothenburg, Sweden, on client-centered innovation and sustainability. This will help the company access to researchers’ knowledge that is socially relevant and applicable.
- In 2021, Getinge opened a new Customer Experience Center to interact with and support customers.
- In 2020, STERIS entered into a definitive agreement to acquire Cantel through a US subsidiary. This acquisition will enable STERIS to offer a larger group of customers a more diverse range of infection prevention products, services and procedures.
- In 2020, Olympus Corporation launched the OER-Elite.
Download PDF brochure:
Leading Key Players and Analysis:
The major players operating in the endoscopic reprocessing market are Cantel Medical (US), Advanced Sterilization Products (ASP) (US), Olympus (Japan), Ecolab (US), STERIS (Ireland), Getinge AB (Sweden), Wassenburg Medical (Netherlands), CONMED Corporation (US), Belimed AG (Switzerland), Endo-Technik W. Griesat (Germany), Custom Ultrasonics (US), Steelco SpA (Italy), BES Healthcare Ltd (UK), ARC Healthcare Solutions (Canada), Metrex Research, LLC. (Canada).
Cantel Medical It is the leading player in the endoscopic reprocessing market with a share of 17.2% in 2020. Cantel offers a wide range of products in the market through its medical business segment. The company has advanced products such as the Advantage Plus series of AERs. AERs provide unprecedented infection control and the lowest cost of ownership. The company holds a large market share in terms of efficiency and performance. A strong focus on research and development and new product development helps the company to be a leader in innovation and accelerate its revenue. The company is also focusing on inorganic growth strategies to strengthen its market position.
For example, in 2020, the company entered into a partnership with Censis Technologies. The partnership brings together a portfolio of endoscopic reprocessing workflows for infection prevention from Cantals, surgical asset management, and device tracking solutions from Censis. These activities helped the company gain a strong foothold in the market.
Geographical analysis in detail?
The laparoscopic reprocessing market is segmented into North America, Europe, Asia Pacific, and Rest of the World. In 2020, North America captured the largest share of the endoscopy market. The larger share of North America can be attributed to factors such as higher incidence of cancer, favorable reimbursement scenarios, and increased incidence of endoscopic-related infections.
Request form pages: https://www.marketsandmarkets.com/requestsampleNew.asp?id=219094994
“High-level disinfectants and test strips are expected to capture the largest share of the endoscope reprocessing market”
based on product, divided into high-level antiseptics and test strips; Detergents and wipes. Endoscopic tracking systems. laparoscopic drying, storage and transportation systems; robotic endoscopic processors (AERs); and other products (brushes and cleaning aids, leak testers, joints, and sponges). In 2020, the high-level disinfectant and test strips segment captured the largest share of the global endoscopic tracing solutions market. The large share of this segment can be attributed to the increased outbreaks associated with inadequate cleaning or disinfection during HLD, the efficacy of high quality assurance-level disinfectants in decontamination of endoscopes, and increased adherence to endoscopic reprocessing guidelines by health care centers.
“Hospitals are expected to have the largest share of the market”
Based on end users, divided into hospitals, centers and clinics for ambulatory surgery and other end users (diagnostic centers, mobile endoscopy facilities, and office endoscopy centers). In 2020, the hospital segment captured the largest share of the global endoscopic reprocessing market. The significant share of this sector can be attributed to the increase in government and private funding, the growth in the healthcare sector in emerging economies, the increase in personal healthcare expenditures worldwide, and the increasing number of endoscopic procedures being performed.
Talk to the analyst: